Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)

Liquidia and Sandoz will collaborate with Mainbridge Health Partners to develop a new infusion pumpLiquidia and Sandoz have also extended the term of their promotion agreement for Treprostinil... | December 5, 2022

Related Keywords

Delaware ,United States ,Scott Moomaw ,Jason Adair ,Liquidia Technologies Inc ,York Heart Association ,United Therapeutics Corporation ,Sandoz Inc ,Drug Administration ,Us District Court ,Smiths Medical Md Inc ,Liquidia Corporation ,Corporate Development ,Mainbridge Health Partners ,Treprostinil Injection ,Senior Vice President ,Pump Agreement ,Abbreviated New Drug Application ,New York Heart Association ,Functional Class ,Dry Powder Inhalation ,United Therapeutics ,Smiths Medical ,Liquidia Technologies ,Health Partners ,Private Securities Litigation Reform Act ,Vice President ,Liquidia Corporation Stock Exchange ,News ,Information ,Press Release ,Liquidia ,End ,Sandoz ,Hill ,Ollaborate ,Ith ,Bainbridge ,Health ,Partners ,O ,Evelop ,Few ,Infusion ,Umpliquidia ,Wave ,Also ,Xtended ,The ,Term ,F ,Their ,Promotion ,Agreement ,Or Lqda Us53635d2027 ,